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Heliannuol is a sesquiterpene that has a benzoxepine ring, oxepin. Many derivatives of benzoxepine 
compounds show anticancer activity by inhibiting the phosphoinositide 3-kinase (PI3K) enzyme.                         
These enzymes play a role in cell proliferation and growth. The study aims to predict the physicochemical 
properties using Lipinski’s Rule of Five parameters on phosphoinositide 3- kinase (PI3K/Mtor; PDB 5OQ4) 
enzyme and the toxicity of Heliannuol A, B, C, D, E compounds. The process uses the pkCSM online tool.        
The validation of receptor 5OQ4 is done using the value parameter RMSD < 2 (Å). Protox online tool dan 
pkCSM online tool is employed to predict the toxicity using parameter LD50, skin sensitization, Ames toxicity, 
hepatotoxicity, and toxicity class. The interaction of ligan and enzyme is tested using Molegro Virtual Docker 
6.0. Heliannoul A, B, C, D, E compounds fulfill Lipinski’s Rule of Five. The receptor 5OQ4 is known valid using 
the value of RMSD 0,923 (Å). Heliannuol A, B, C, D, E compounds inhibit Dual PI3K / mTOR enzyme less than 
Bimiralisib. As a result of the toxicity test of compounds Helliannouls A, B, C, E, and Bimiralisib compounds 
are included in class 4, while Helliannouls D compounds are included in class 5. 
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INTRODUCTION  
Brain cancer covers about 85-90% of all 
central nervous system cancers. The incidence rate 
for malignant brain cancer worldwide based on 
world standard population rates is 3.4 per 100,000 
population. The mortality rate is 4.25 per 100,000 
population per year. Understanding the molecular 
principles and signaling pathways involved in 
glioblastoma is essential for the development of 
more effective therapies. (AnZhenyi et al., 2018; 
(Pedoman Nasional Pelayanan Kedokteran Tumor 
Otak, 2017). 
The phosphoinositide 3-kinase signaling 
pathway have a central role in the regulation of 
signal transduction, mediating various biological 
processes, including cell proliferation, apoptosis, 
metabolism, motility, and angiogenesis in 
glioblastoma. Excessive activation of the PI3K or 
Akt pathway provides rapid growth, tumor 
development, and multi-drug resistance to 
glioblastoma cells (Zhao et al., 2017). 
Heliannuols is a new group of phenolic 
sesquiterpenes isolated from sunflower cultivars 
(Helianthus annuus). The chemical structure of 
Heliannuols has a benzoxepine ring in which 
various benzoxepine derivatives have shown 
activity    towards      various     types     of      cancer.  
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The benzoxepine derivative mechanism inhibits 
the enzyme phosphoinositide 3- kinase (PI3K) 
(Hefron et al., 2011; Kuntala et al., 2017). 
The insilico test is a method through 
simulation carried out with computer media. In 
silico test was conducted by tethering the molecule 
(molecular docking) Selected drug candidates to 
the receptor. In Silico testing has the advantage of 
efficiently finding new drugs using a modeling 
method that is a simulation with the help of 
computational technology (Pelkonen et al., 2011).  
Prediction of drug activity at the receptors can be 
performed using in silico test. 
This research was carried out because, in 
the development of cancer drugs, it was needed to 
predict anticancer activity, toxicity, and 
physicochemical properties, research of 
Heliannuol A, B, C, D, E compounds contained in 
sunflower plants (Helianthus annus L.) towards 




Tools: Chem Bio Draw Ultra Version 12 
(CambridgeSoft), Avogadro, Molegro Virtual 
Docker 6.0, protox online tool, pkCSM online tool. 
Ingredients: Dual PI3K / mTOR enzyme (5OQ4), 
protein subtype: gamma isoform subunit, Native 
Ligand: 5- (4,6-dimorpholin-4-yl-1,3,5-triazine-2-
yl)    - 4- (trifluoromethyl)     pyridin-2-amine     or  
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bimiralisib (PQR309), resolution: 2.70 Å; 2-
dimensional and 3-dimensional structures of 
Heliannuol A, B, C, D, E, and Bimiralisib compounds 
along with the SMILE code. 
 
Methods 
Ligand Preparation and Receptors 
Receptor preparation was done through 
downloading on the protein data bank website 
https://www.rcsb.org/structure/5OQ4. Ligand 
preparation was done by drawing ligands in 2D 
and obtained the SMILE code used Chem Bio Draw 
Ultra version 12. Then 3D was changed using 
Avogadro. Geometry optimization using Avogadro 
with the MMFF94 method. 
 
Physicochemical Test 
The Physicochemical prediction was carried 
out using Lipinski parameter 5 was molecular 
weight, the logarithm of octanol/water partition 
coefficient, number of bonds between rotating 
atoms, Hydrogen Bond Acceptors, Hydrogen Bond 
Donors, and Polar Surface Activity by entering 
SMILE code into the online tool pkCSM. 
 
Determination of Cavity 
The determination of the cavity was used to 
detect the location of the ligand with 5OQ4 
receptors. The selection was made by looking at 
the native sites of the ligands that interact with the 




The validation parameter seen was the 
value of RMSD (Root Mean Square Deviation) 
through backing natives with receptors. Validation 
was done by re-docking between native ligands 
and 5OQ4 receptors. 
 
Docking Heliannuols A, B, C, D, E, and 
Bimiralisibat the 5OQ4 receptor 
Docking Heliannuols A, B, C, D, E, and 
Bimiralisib were performed used Molegro Virtual 
Docker 6.0. RS value (rerank score) was the bond 
energy needed to form bonds between ligands and 
receptors so that the activity of a compound can be 
predicted (Zaidan et al., 2019). 
 
Toxicity Test 
Prediction of compound toxicity based on 
skin sensitization, Ames toxicity, Hepatotoxicity, 
LD50 using the online Protox tool, and online 




RESULT AND DISCUSSION  
This research aims to predict 
physicochemical properties with the legal 
parameters of five Lipinski, activity towards the 
phosphoinositide 3-kinase enzyme (PI3K/ mTOR; 
PDB 5OQ4), and the toxicity of the compounds 
Heliannuols A, B, C, D, E. 
 
Ligand Preparation and Receptors 
The Dual PI3K / mTOR (5OQ4) enzyme was 
used as a receptor protein and the ligand used is 
the compound Heliannuol A, B, C, D, E with the 
comparative compound Bimiralisib. The results of 
two-dimensional images are shown in figure 1.    
The process of geometry optimization aims to 
minimize energy to obtain the most stable 
structure (Susanti et al., 2018). The results of          
the geometry optimization of Heliannuol A, B, C, D, 




The physicochemical test aims to predict the 
absorption properties of the compounds 
Heliannuols A, B, C, D, E, Bimiralisib. Compounds 
have low absorption if there are more than five 
donor H-bonds (expressed as the number of OH 
and NH), molecular weights more than 500, Log P 
is more than 5, and there are more than 10 H-bond 
acceptors (expressed as the number of Ns and Os) 
(Lipinski et al., 2011). Prediction results of 
physicochemical properties can be seen in             
table II. 
The results of the analysis in table II that the 
compounds Heliannuols A, B, C, D, E, comparative 
compounds (Bimiralisib) meet the five Lipinski 
legal requirements, the compounds are predicted 
to be easily absorbed. They have good 
permeability, so it requires further testing related 
to distribution, metabolism, and excretion in a 
manner in silico. 
 
Determination of Cavity 
Native sites of binding ligands have 
potential as active holes so that they can be used 
for docking ligands from the compound Heliannoul 
A. B, C, D, E, Bimiralisib. The cavity at the receptor 
is shown in green. figure 2 A (A) shows the five 
cavities that may interact with the 5OQ4 receptor. 
The five cavities were selected by looking at the 
places of native ligands that interact with receptors 
5OQ4. The results of cavity determination can be 
seen in figure 2. The results of the selection 
obtained one cavity, namely volume 452.608, with 
a surface area of 1149.44. 
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Figure 1: Two-dimensional structure of Heliannuols A (A); Two-dimensional structure of Heliannuols B (B); 
Two-dimensional structure of Heliannuols C (C); Two-dimensional structure of Heliannuols D (D); Two-
dimensional structure of Heliannuols E (E); Two-dimensional structure Bimiralisib dimension (F). 
 




Minimum Energy (Kcal/mol) Average (Kcal/mol), 
± SD Replication I Replication II Replication III 
Heliannuols A 75,835 75,835 75,834 75,835 ± 0,0003 
Heliannuols B 76,461 76,462 76,460 76,461 ± 0,0010 
Heliannuols C 67,480 67,480 67,480 67,480± 0,0001 
Heliannuols D 63,585 63,585 63,585 63,585± 0,0000 
Heliannuols E 54,188 54,188 54,188 54,188 ± 0,0000 
Bimiralisib 67,265 67,265 67,265 67,265 ± 0,0000 
 
Table II. Results of the determination of physicochemical properties and prediction of toxicity to the 
compounds Heliannuols A, B, C, D, E, Bimiralisib 
 
Compound 





BM (g/mol) Log P Torsion HBA HBD 
Heliannuols A 250.338 3.11622 0 3 2 108.412 Yes 
Heliannuols B 248.322 2.89222 1 3 2 107.722 Yes 
Heliannuols C 248.322 2.89222 1 3 2 107.722 Yes 
Heliannuols D 250.338 3.11622 1 3 2 108.412 Yes 
Heliannuols E 248.322 2.89222 2 3 2 107.722 Yes 
Bimiralisib 410.4 1.8128 3 8 1 165.004 Yes 
 
Note: BM (Molecular weight) <500; Log P (The logarithm of octanol/water partition coefficient <5;  









Figure 2. The results of cavity detection at the 5OQ4 receptor (A); Cavity that binds to the native ligand 
5OQ4 receptor (cavity 2 (B)) 
 
Note Figure 2A : Cavity 1 Vol = 1339.39 Surface = 2714.88; Cavity 2 Vol = 452.608 Surface = 1149.44; 
Cavity 3 Vol = 285.696 Surface = 697.6; Cavity 4 Vol = 143.872 Surface = 559.36; Cavity 5 Vol = 73.216 
Surface = 243.2 
Note Figure 2B : Red: Heliannuols A; Yellow: Heliannuols B; Green: Heliannuols C; Blue: Heliannuols D; 
Purple: Heliannuols E; Pink: Bimiralisib 
 
   
(A) (B) (C) 
   
(D) (E) (F) 
 
Figure 3. The results of two-dimensional interaction of hydrogen bonds (blue line) and steric bonds (red 
lines) Heliannuols A (A); Heliannuols B (B); Heliannuols C (C); Heliannuols D (D); Heliannuols E (E); 
Bimiralisib(F) compounds with the 5OQ4 receptor amino acid. 
 





Replication I Replication II Replication III 
Nilai RMSD 0,99 0,8 0,98 0,923 ; ± 0,1069 
Rerank Score -99 -99 -102 -100 ; ± 1,4930 
Moldock Score -113 -107 -118 -113 ; ± 5,1411 
 
Note : RMSD : A deviation value that represents the ratio between the ligand receptor conformation in the 
simulation process and the initial ligand-receptor conformation (Dermawan et al., 2019). 
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Method Validation 
The validation of the method was replicated 
three times by re-docking the native ligand with 
the hole (cavity 2) of the 5OQ4 target protein 
receptor.   Based    on    the    results   of   re-docking,             
the average RMSD value is 0.923 Å, which indicates 
that the docking method meets the validity criteria, 
so that the parameter can be used for docking the 
test compound (Muttaqin et al., 2019). The results 
of research validation can be seen in Table III. 
 
Molecular Docking and Amino Acid Interaction 
The 5OQ4 receptor docking analysis (an 
enzyme of Dual PI3K /mTOR) of Heliannuols A, B, 
C, D, E compounds are obtained. The lowest 
average rerank score was -69,000 Kcal/mol in 
Heliannuol E test compound so that it has the 
highest activity compared to Heliannuols 
compounds A, B, C, D. Bond energy shows the 
amount of energy needed to form bonds between 










Figure 4. Three-dimensional form of interaction between Heliannuols A (A); Heliannuols B (B); Heliannuols 
C (C); Heliannuols D (D); Heliannuols E (E); and Bimiralisib compounds with the amino acid receptor 5OQ4. 
 
Note : Red: Heliannuols A; Yellow: Heliannuols B; Green: Heliannuols C; Blue: Heliannuols D; Purple: 
Heliannuols E; Pink: Bimiralisib. 
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means, the more stable the bond is. The more 
stable the ligand binds with the receptor, it can be 
predicted that the activity will also be more 
significant (Hardjono, 2016). 
The bonds formed between the groups in 
the ligand with the receptors are essential in 
determining the affinity formed. The OH group 
bond with the receptor causes the rerank score of 
Heliannuols A, B, C, D, E to be more excellent, and 
the bonding groups F, N, and O on the Bimiralisib 
causes the value of the score to be smaller, so it has 
a greater affinity. It is because in Bimiralisib there 
are   more   bonds   with   groups   that   have   large  
electronegativity so that they have a stronger 
hydrogen bond compared to Heliannuols A, B, C, D, 
E. The results of ligand interactions with amino 
acids in the 5OQ4 receptor are shown in and in 
table V and figure 2. 
Figure 3 shows the interaction of hydrogen 
bonds in Aspartic 964 amino acid residues in 
Table V. Results of Interactions with Amino Acids 
 
Compound 
Hydrogen Bonding Steric Bonding 
Amino Acid (Distance (Å)) Ligand Group Amino Acid (Distance (Å)) Ligand Group 
Heliannuols A Glu 880 (3,00) OH Ile 963 (3,12)  
Ile 831 (3,00) 




Heliannuols B Val 882 (2,73) 







































Heliannuols E Glu 880 (3,10) 
Val 882 (3,09) 
OH 
OH 








Bimiralisib Asp 836 (2,61) 
Val 882 (3,12) 
Asp 841 (3,42) 





























Heliannuols A 860 No No No 4 
Heliannuols B 482 No No No 4 
Heliannuols C 500 No No No 4 
Heliannuols D 2148 No No No 5 
Heliannuols E 500 No No No 4 
Bimiralisib 2000 No Yes No 4 
 
Note : * Using Protox II Online Tool; ** Using pkCSM Online Tool 
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Bimiralsib which binds to NH2 groups also occur in 
Heliannuol C, D compounds that bind to OH ligand 
groups, but do not occur in Heliannuol A and E. 
Compounds. At the same time, hydrogen bonds 
with acid residues Amino Valin 882 in Bimiralisib 
also occur in Heliannuols B and E. The hydrogen 
bond occurs when a bond between an H atom has 
a partial positive charge and another 
electronegative atom and has a pair of free 
electrons with complete octets such as O, N, and F 
(F, Siswandono, 2016). 
Whereas steric interactions in Bimiralisib 
occur in amino acids Isoleucine 963, Glutamate 
880, Aspartate 841 which also binds to       
Heliannuol A, C, D, E. Compounds Steric                 
bonds are involved in the interaction of benzene 
rings  with  the  plane  of the receptor                          
plane and in the interaction of the hydrocarbon 
chain with macromolecules or receptors 
(Siswandono, 2016). 
Research Bianchi et al., 2004 explained that 
glioblastoma growth is associated with increased 
concentrations of choline, GABA, isoleucine, 
leucine, lysine, phenylalanine, taurine, tyrosine, 
and valine. In grade III and grade IV tumors in 
concentrations of extracellular phenylalanine, 
isoleucine, tyrosine, valine, and lysine, all are 
increased compared to normal tissue. 
 
Toxicity Test 
The next In Silico research was to predict the 
compounds Heliannuol A, B, C, D, E, Bimiralisib. 
Toxicity prediction results are shown in Table VI, 
obtained LD50 values of Heliannuol D compound 
(toxicity class 5 (2000 <LD50 ≤ 5000 mg/kg)) 
greater than Heliannuol A, B, C, E and comparative 
compounds (Bimiralisib) with class toxicity 4 (300 
<LD50 ≤ 200 mg/kg) so it is predicted that the 
toxicity of the compound Heliannuol D is low.  
 
CONCLUSION 
Helliannouls A, B, C, D, E compounds are 
predicted to have good absorption properties and 
to inhibit the Dual PI3K/mTOR enzyme is 
predicted not to be greater than Bimiralisib In Silico 
with a Bimiralisib score of -99.668 Kcal/mol.         
The toxicity of the compound Helliannouls A, B, C, 
E, and the compound Bimiralisib belong to class 4 
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